Brain Cancer Research Today is a free monthly online journal that collates and summarizes the latest research about Brain Cancer, including details on symptoms, benign and malignant tumors, gliomas, treatment.

Volume 6 (2009), Issue 11 (November)

1. Use of 5-aminolevulinic acid for visualization and resection of a benign pediatric brain tumor.
   J Neurosurg Pediatr, 4(5): 484-6. [Abstract] [Full-text]
2. Post-radiation reactive changes in a single vertebral body mimicking metastatic pineoblastoma.
   J Neurosurg Pediatr, 4(5): 479-83. [Abstract] [Full-text]
3. From glioblastoma to gangliocytoma: an unforeseen but welcome shift in biological behavior.
   J Neurosurg Pediatr, 4(5): 475-8. [Abstract] [Full-text]
4. Harvey Cushing as a book collector, bibliophile, and archivist: the precedence for the genesis of the Brain Tumor Registry. Historical vignette.
   J Neurosurg, 111(5): 1091-5. [Abstract] [Full-text]
5. Treatment and outcomes of primary intracranial teratoma.
   Childs Nerv Syst, 25(12): 1581-7. [Abstract] [Full-text]
6. Ultrastructural evidence of ependymal differentiation in a genetically proven atypical teratoid/rhabdoid tumor.
   Childs Nerv Syst, 25(12): 1627-31. [Abstract] [Full-text]
7. Grade II atypical choroid plexus papilloma with normal karyotype.
   Childs Nerv Syst, 25(12): 1623-6. [Abstract] [Full-text]
8. Intracranial tumors in first year of life: the CHEO experience.
   Childs Nerv Syst, 25(12): 1563-9. [Abstract] [Full-text]
9. Osteosarcoma presenting as hemorrhagic cerebellar metastasis.
   Childs Nerv Syst, 25(12): 1643-7. [Abstract] [Full-text]
10. The importance of tumor volume in the prognosis of patients with glioblastoma: comparison of computerized volumetry and geometric models.
    Strahlenther Onkol, 185(11): 743-50. [Abstract] [Full-text]
11. Hypoxia promotes expansion of the CD133-positive glioma stem cells through activation of HIF-1alpha.
    Oncogene, 28(45): 3949-59. [Abstract] [Full-text]
12. Loss of collapsin response mediator Protein1, as detected by iTRAQ analysis, promotes invasion of human gliomas expressing mutant EGFRvIII.
    Cancer Res, 69(22): 8545-54. [Abstract] [Full-text]
13. yuDetecting the percent of peripheral blood mononuclear cells displaying p-STAT-3 in malignant glioma patients.
    J Transl Med, 7: 92. [Abstract] [Full-text]
14. The dexamethasone-induced inhibition of proliferation, migration, and invasion in glioma cell lines is antagonized by macrophage migration inhibitory factor (MIF) and can be enhanced by specific MIF inhibitors.
    J Biol Chem, 284(47): 32483-92. [Abstract] [Full-text]
15. Caveolin-1 expression in diffuse gliomas: correlation with the proliferation index, epidermal growth factor receptor, p53, and 1p/19q status.
    Hum Pathol, 40(12): 1738-46. [Abstract] [Full-text]
16. Bevacizumab for recurrent ependymoma.
    Neurology, 73(20): 1677-80. [Abstract] [Full-text]
17. Age, stage, and radiotherapy, but not primary tumor site, affects the outcome of patients with malignant rhabdoid tumors.
    Pediatr Blood Cancer, 54(1): 35-40. [Abstract] [Full-text]
18. Immune gene and cell enrichment is associated with a good prognosis in ependymoma.
    J Immunol, 183(11): 7428-40. [Abstract] [Full-text]
19. IDH1 mutations in low-grade astrocytomas predict survival but not response to temozolomide.
    Neurology, 73(21): 1792-5. [Abstract] [Full-text]
20. Gamma knife radiosurgery: a safe and effective salvage treatment for pituitary tumours not controlled despite conventional radiotherapy.
    Eur J Endocrinol, 161(6): 819-28. [Abstract] [Full-text]
21. Stereotactic interstitial radiosurgery with the Photon Radiosurgery System (PRS) for metastatic brain tumors: a prospective single-center clinical trial.
    Int J Radiat Oncol Biol Phys, 75(5): 1392-400. [Abstract] [Full-text]
22. Adult supratentorial low-grade glioma: long-term experience at a single institution.
    Int J Radiat Oncol Biol Phys, 75(5): 1401-7. [Abstract] [Full-text]
23. Imaging after GliaSite brachytherapy: prognostic MRI indicators of disease control and recurrence.
    Int J Radiat Oncol Biol Phys, 75(5): 1385-91. [Abstract] [Full-text]
24. Brain metastases admissions in Sweden between 1987 and 2006.
    Br J Cancer, 101(11): 1919-24. [Abstract] [Full-text]
25. Cribriform neuroepithelial tumor (CRINET): a nonrhabdoid ventricular tumor with INI1 loss and relatively favorable prognosis.
    J Neuropathol Exp Neurol, 68(12): 1249-55. [Abstract] [Full-text]
26. Diagnostic use of IDH1/2 mutation analysis in routine clinical testing of formalin-fixed, paraffin-embedded glioma tissues.
    J Neuropathol Exp Neurol, 68(12): 1319-25. [Abstract] [Full-text]
27. Molecular predictors of progression-free and overall survival in patients with newly diagnosed glioblastoma: a prospective translational study of the German Glioma Network.
    J Clin Oncol, 27(34): 5743-50. [Abstract] [Full-text]
28. Survival after second primary neoplasms of the brain or spinal cord in survivors of childhood cancer: results from the British Childhood Cancer Survivor Study.
    J Clin Oncol, 27(34): 5781-7. [Abstract] [Full-text]
29. Non-apoptotic Fas signaling regulates invasiveness of glioma cells and modulates MMP-2 activity via NFkappaB-TIMP-2 pathway.
    Cell Signal, 22(2): 212-20. [Abstract] [Full-text]
30. Challenges in clinical design of immunotherapy trials for malignant glioma.
    Neurosurg Clin N Am, 21(1): 201-14. [Abstract] [Full-text]
31. Monitoring immune responses after glioma vaccine immunotherapy.
    Neurosurg Clin N Am, 21(1): 195-9. [Abstract] [Full-text]
32. Distinguishing glioma recurrence from treatment effect after radiochemotherapy and immunotherapy.
    Neurosurg Clin N Am, 21(1): 181-6. [Abstract] [Full-text]
33. Virally mediated immunotherapy for brain tumors.
    Neurosurg Clin N Am, 21(1): 167-79. [Abstract] [Full-text]
34. Glioma stem cell research for the development of immunotherapy.
    Neurosurg Clin N Am, 21(1): 159-66. [Abstract] [Full-text]
35. Dendritic cell vaccines for brain tumors.
    Neurosurg Clin N Am, 21(1): 139-57. [Abstract] [Full-text]
36. Heat shock proteins in glioblastomas.
    Neurosurg Clin N Am, 21(1): 111-23. [Abstract] [Full-text]
37. Clinical applications of a peptide-based vaccine for glioblastoma.
    Neurosurg Clin N Am, 21(1): 95-109. [Abstract] [Full-text]
38. The epidermal growth factor variant III peptide vaccine for treatment of malignant gliomas.
    Neurosurg Clin N Am, 21(1): 87-93. [Abstract] [Full-text]
39. Interferon-gamma in brain tumor immunotherapy.
    Neurosurg Clin N Am, 21(1): 77-86. [Abstract] [Full-text]
40. Passive antibody-mediated immunotherapy for the treatment of malignant gliomas.
    Neurosurg Clin N Am, 21(1): 67-76. [Abstract] [Full-text]
41. Immunostimulants for malignant gliomas.
    Neurosurg Clin N Am, 21(1): 53-65. [Abstract] [Full-text]
42. Microglia and central nervous system immunity.
    Neurosurg Clin N Am, 21(1): 43-51. [Abstract] [Full-text]
43. Glioblastoma-derived mechanisms of systemic immunosuppression.
    Neurosurg Clin N Am, 21(1): 31-42. [Abstract] [Full-text]
44. Mechanisms of local immunoresistance in glioma.
    Neurosurg Clin N Am, 21(1): 17-29. [Abstract] [Full-text]
45. A mathematical model of brain tumour response to radiotherapy and chemotherapy considering radiobiological aspects.
    J Theor Biol, 262(3): 553-65. [Abstract] [Full-text]

© 2004-2012 Brain Cancer Research Today. All Rights Reserved.